Clinical Trial Update: A Study to Continue the Administration of Deucravacitinib in Participants With Systemic Lupus Erythematosus (SLE) or Discoid and/or Subacute Cutaneous Lupus Erythematosus (DLE/SCLE) Who Have Completed Study IM011074 or Study IM011132 [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update indicating that deucravacitinib is being studied in participants with systemic lupus erythematosus (SLE) or discoid and/or subacut…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Discoid Lupus Erythematosus
• Subacute Cutaneous Lupus Erythematosus
• Systemic Lupus Erythematosus

Drugs mentioned

• Sotyktu (Deucravacitinib)

Snippet

Sponsor: Bristol-Myers Squibb | Conditions: Systemic Lupus Erythematosus (SLE), Discoid and/or Subacute Cutaneous Lupus Erythematosus (DLE/SCLE) | Phase 4 | Status: RECRUITING